halobetasol and its Impurities

Also known in the name of Ulobetasol , it is a corticosteroid which is used to treat inflammation and itching of the skin. Halobetasol is used for treating psoriosis, eczema, insect bites, rashes, allergies, and dermatitis. Reference standards of Halobetasol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 13 results for halobetasol Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 08 01000

Halobetasol

Halobetasol


  • Catalogue No.:PA 08 01000

  • CAS :

    98651-66-2

  • Molecular Formula : C22H27ClF2O4

  • Molecular Weight : 428.9

Drug Reference Standards & Impurity Synthesis in India
PA 08 01510

(6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione

(6α,11β,16β)-21-Chloro-6,9-difluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione


  • Catalogue No.:PA 08 01510

  • CAS :

    66852-54-8

  • Molecular Formula : C25H31ClF2O5

  • Molecular Weight : 484.96

Drug Reference Standards & Impurity Synthesis in India
PA 08 0011000

(6S,8S,9R,10S,11S,13S,14S)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one

(6S,8S,9R,10S,11S,13S,14S)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one


  • Catalogue No.:PA 08 0011000

  • CAS :

    NA

  • Molecular Formula : C22H25ClF2O3

  • Molecular Weight : 410.89

Drug Reference Standards & Impurity Synthesis in India
PA 08 0011001

(6R,9R,11S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate

(6R,9R,11S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate


  • Catalogue No.:PA 08 0011001

  • CAS :

    NA

  • Molecular Formula : C25H31ClF2O5

  • Molecular Weight : 484.96

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001001

(10S,13S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-11-hydroxy-3-methoxy-10,13,16-trimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate

(10S,13S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-11-hydroxy-3-methoxy-10,13,16-trimethyl-2,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl propionate


  • Catalogue No.:PAI 08 001001

  • CAS :

    NA

  • Molecular Formula : C26H36ClFO5

  • Molecular Weight : 483.02

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001002

1-((9R,10S,13S,16S,17R)-9-Fluoro-11,17-dihydroxy-3-methoxy-10,13,16-trimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-7H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyethan-1-one

1-((9R,10S,13S,16S,17R)-9-Fluoro-11,17-dihydroxy-3-methoxy-10,13,16-trimethyl-8,9,10,11,12,13,14,15,16,17-decahydro-7H-cyclopenta[a]phenanthren-17-yl)-2-hydroxyethan-1-one


  • Catalogue No.:PAI 08 001002

  • CAS :

    NA

  • Molecular Formula : C23H31FO5

  • Molecular Weight : 406.49

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001003

2-((4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2-(Benzoyloxy)-7-hydroxy-4a,6a,8-trimethyl-4a,5a,6,6a,7,8,9,9a,9b,10-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl benzoate

2-((4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-2-(Benzoyloxy)-7-hydroxy-4a,6a,8-trimethyl-4a,5a,6,6a,7,8,9,9a,9b,10-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl benzoate


  • Catalogue No.:PAI 08 001003

  • CAS :

    924726-86-3

  • Molecular Formula : C36H36O7

  • Molecular Weight : 580.68

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001004

2-((4aS,4bS,5aS,6aS,7R,8S,9aS,9bS,11S)-11-Fluoro-7-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl benzoate

2-((4aS,4bS,5aS,6aS,7R,8S,9aS,9bS,11S)-11-Fluoro-7-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl benzoate


  • Catalogue No.:PAI 08 001004

  • CAS :

    924726-87-4

  • Molecular Formula : C29H31FO6

  • Molecular Weight : 494.56

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001005

(4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-7-(2-Acetoxyacetyl)-7-hydroxy-4a,6a,8-trimethyl-4a,5a,6,6a,7,8,9,9a,9b,10-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2-yl benzoate

(4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-7-(2-Acetoxyacetyl)-7-hydroxy-4a,6a,8-trimethyl-4a,5a,6,6a,7,8,9,9a,9b,10-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2-yl benzoate


  • Catalogue No.:PAI 08 001005

  • CAS :

    182202-37-5

  • Molecular Formula : C31H34O7

  • Molecular Weight : 518.61

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001006

2-((4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-11-Fluoro-7-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl acetate

2-((4aS,4bS,5aS,6aS,7R,8S,9aS,9bS)-11-Fluoro-7-hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl acetate


  • Catalogue No.:PAI 08 001006

  • CAS :

    NA

  • Molecular Formula : C24H29FO6

  • Molecular Weight : 432.49

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001007

(4aS,4bS,5aS,6aS,7R,8S,9aS,9bS,11S)-11-Fluoro-7-hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one

(4aS,4bS,5aS,6aS,7R,8S,9aS,9bS,11S)-11-Fluoro-7-hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one


  • Catalogue No.:PAI 08 001007

  • CAS :

    82662-44-0

  • Molecular Formula : C22H27FO5

  • Molecular Weight : 390.45

Drug Reference Standards & Impurity Synthesis in India
PAI 08 001008

(4aS,4bS,5aS,6aS,7R,8S,9aS,9bS,11S)-7-(2-Chloroacetyl)-11-fluoro-7-hydroxy-4a,6a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one

(4aS,4bS,5aS,6aS,7R,8S,9aS,9bS,11S)-7-(2-Chloroacetyl)-11-fluoro-7-hydroxy-4a,6a,8-trimethyl-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one


  • Catalogue No.:PAI 08 001008

  • CAS :

    NA

  • Molecular Formula : C22H26ClFO4

  • Molecular Weight : 408.89

Drug Reference Standards & Impurity Synthesis in India
PA 08 0011002

(6R,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate

(6R,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate


  • Catalogue No.:PA 08 0011002

  • CAS :

    NA

  • Molecular Formula : C25H31ClF2O5

  • Molecular Weight : 484.96

pharmaffiliates